Graft Versus Host Disease
Showing NaN - NaN of 9
Sickle Cell Disease, GVHD Trial in United States (Diphenhydramine, Acetaminophen, Methylprednisolone)
Active, not recruiting
- Sickle Cell Disease
- Graft Versus Host Disease
- Diphenhydramine
- +15 more
-
Washington, District of Columbia
- +6 more
Aug 4, 2021
B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, GVHD Trial in Australia,
Completed
- B-cell Childhood Acute Lymphoblastic Leukemia
- +5 more
- thiotepa
- +5 more
-
Phoenix, Arizona
- +49 more
Jul 24, 2019
GVHD Trial in Chapel Hill (efalizumab)
Terminated
- Graft Versus Host Disease
- efalizumab
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Apr 12, 2017
GVHD, Lymphoma Trial in United States (carmustine, melphalan, etoposide)
Completed
- Graft Versus Host Disease
- Lymphoma
- carmustine
- +7 more
-
Birmingham, Alabama
- +47 more
Jul 15, 2016
GVHD, Systemic Scleroderma Trial in United States (imatinib mesylate, rituximab)
Completed
- Graft Versus Host Disease
- Systemic Scleroderma
- imatinib mesylate
- rituximab
-
Scottsdale, Arizona
- +9 more
May 10, 2016
GVHD, Leukemia, Lymphoma Trial in United States (biological, drug, procedure, radiation)
Completed
- Graft Versus Host Disease
- +4 more
- anti-thymocyte globulin
- +6 more
-
Gainesville, Florida
- +16 more
Mar 3, 2011
GVHD, Leukemia, MDS Trial in United States (biological, drug, procedure, radiation)
Completed
- Graft Versus Host Disease
- +3 more
- anti-thymocyte globulin
- +7 more
-
Gainesville, Florida
- +14 more
Mar 3, 2011
GVHD Trial in Chapel Hill (mycophenolate mofetil)
Completed
- Graft Versus Host Disease
- mycophenolate mofetil
-
Chapel Hill, North CarolinaUniversity of North Carolina School of Medicine
Jun 23, 2005